Answer: AWS offers scalable compute, security, and managed AI tools for experimentation

**Explanation:** Option B is correct because AWS provides comprehensive infrastructure and services that are essential for generative AI use cases in life sciences: 1. **Scalable compute**: AWS offers elastic computing resources (like EC2 instances, SageMaker) that can handle the intensive computational requirements of molecular structure analysis and drug compound simulation. 2. **Security**: AWS provides robust security features and compliance certifications that are crucial for handling sensitive research data in life sciences. 3. **Managed AI tools**: Services like Amazon SageMaker, AWS HealthOmics, and other AI/ML services provide managed environments for experimentation without the overhead of infrastructure management. 4. **Flexibility**: AWS allows researchers to experiment with different models, frameworks, and approaches in a cost-effective manner. **Why other options are incorrect:** - **A**: AWS does not automatically validate all molecular results - validation requires scientific expertise and experimental verification. - **C**: Model fairness is important but not a guarantee, and it's not the core benefit for this specific use case of drug compound simulation. - **D**: AWS AI tools augment and assist researchers rather than replacing them entirely, maintaining the critical human expertise needed in drug discovery. This use case demonstrates how AWS supports generative AI applications in scientific research by providing the necessary infrastructure, tools, and security while enabling researchers to focus on innovation rather than infrastructure management.

Author: Jin H